Ronald W. Barrett

Insider Reports History

Location
Santa Clara, CA
Signature
/s/ James Pennington, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ronald W. Barrett:

Company Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Director Common Stock 6,250 $159,750 $25.56 11 Jun 2025 Direct
CONCERT PHARMACEUTICALS, INC. Director Common Stock 5,125 $42,691 $8.33 10 Jun 2021 Direct
Janux Therapeutics, Inc. Director Stock Option (right to buy) 11,667 11 Jun 2025 Direct
CONCERT PHARMACEUTICALS, INC. Director Stock Option (right to buy) 10,250 10 Jun 2021 Direct

Insider Reports Filed by Ronald W. Barrett

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JANX Janux Therapeutics, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 19:30
JANX Janux Therapeutics, Inc. 26 Jun 2024 2 $0 4 Director 28 Jun 2024, 16:30
JANX Janux Therapeutics, Inc. 14 Jun 2023 1 $0 4 Director 16 Jun 2023, 17:06
JANX Janux Therapeutics, Inc. 14 Jun 2022 1 $0 4 Director 16 Jun 2022, 16:39
JANX Janux Therapeutics, Inc. 07 Sep 2021 1 $0 4 Director 09 Sep 2021, 17:34
JANX Janux Therapeutics, Inc. 07 Sep 2021 0 $0 3 Director 09 Sep 2021, 17:26
/report/000120919121039743-barrett-ronald-w-2021-06-10 CONCERT PHARMACEUTICALS, INC. 10 Jun 2021 2 $0 4 Director 11 Jun 2021, 08:38